Clarivate Plc (CLVT)

Blueprint Medicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,588	3,609	6,148	5,623	16,151	18,003
Market Cap Growth	-22.75%	-41.30%	9.33%	-65.18%	-10.29%	250.14%
Enterprise Value	6,827	7,963	12,092	12,148	20,462	19,437
Last Close Price	3.85	5.08	9.26	8.34	23.52	29.71
Forward PE	5.84	7.05	11.31	11.13	27.13	42.66
PS Ratio	1.08	1.41	2.34	2.11	8.61	14.36
PB Ratio	0.52	0.70	1.03	0.83	1.35	1.99
P/FCF Ratio	7.48	10.10	12.25	18.35	78.67	115.55
P/OCF Ratio	4.10	5.58	8.26	11.04	49.88	68.32
EV/Sales Ratio	2.73	3.12	4.60	4.57	10.90	15.50
EV/EBITDA Ratio	7.14	8.29	12.30	12.44	34.11	70.65
EV/EBIT Ratio	31.43	34.00	44.02	45.62	329.51	-
EV/FCF Ratio	19.73	22.28	24.10	39.65	99.67	124.76
Debt / Equity Ratio	0.92	0.89	0.80	0.75	0.47	0.40
Debt / EBITDA Ratio	4.88	4.66	4.76	5.07	8.90	12.04
Debt / FCF Ratio	13.26	12.85	9.59	16.66	27.34	23.31
Asset Turnover	0.21	0.21	0.20	0.16	0.11	0.14
Quick Ratio	0.80	0.76	0.80	0.79	0.70	0.70
Current Ratio	0.91	0.87	0.91	0.89	0.86	0.81
Return on Equity (ROE)	-8.18%	-11.44%	-14.23%	-42.27%	-2.58%	-6.82%
Return on Assets (ROA)	0.94%	1.21%	1.29%	0.97%	0.22%	-0.19%
Return on Capital (ROIC)	1.11%	1.43%	1.51%	1.13%	0.26%	-0.22%
Return on Capital Employed (ROCE)	1.80%	2.30%	2.50%	2.20%	0.30%	-
Earnings Yield	-16.74%	-17.64%	-14.82%	-70.43%	-1.68%	-1.95%
FCF Yield	13.37%	9.91%	8.16%	5.45%	1.27%	0.86%
Buyback Yield / Dilution	-3.91%	-3.28%	1.03%	-5.90%	-50.07%	-55.91%

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q